What’s Different Now
In just one month, life for all of us has changed dramatically. This week, we learned that the new normal would extend at least through April, probably longer.
Biopharma Brand Planning Strategy: Vision, Imperatives, and Tactics
Many years ago, when we first started working with emerging life sciences companies to provide a roadmap for the commercialization of their technologies, we began with a list of essential activities and the corresponding budget that would be required.
Biopharma Governance and Decision-Making: How to Fix What’s Broken
At your next company lunch and learn, try this experiment: Ask ten people from different functions to take a blank piece of flip chart paper (assuming you still have flip charts!). Then ask them to draw a picture of how key decisions are made in your organization.
Are Your Assumptions Serving You Well?
Ah, June, the season of life transitions — weddings, graduations, school progression and, with the year nearly half over, a reminder to reflect on where we have been and where we are going in 2019.
Biopharma Launch Planning for Emerging Companies: Four Key Challenges
Living in a parallel universe, launching a company and drug simultaneously.
The Sound of Silos
We have all heard about it; some of us have lived it firsthand. A vibrant, new start-up comes to life with energy and purpose. Everyone knows one another; everyone works together towards a common goal. Communication happens on the fly, informally, at all hours of the day and night. It’s fast and it’s fun — we are a tight group, proud of what we are building.
Nature vs. Nurture
We have been publishing these "e-conversations" for just six months now. But I am happy — no, thrilled — to see that it has already become exactly what we had hoped for: a two-way conversation with all of you.